The Pharmacy Stakeholder Forum is a joint initiative between the Pharmacy Council of NSW, NSW Ministry of Health and other pharmacy organisations representing most NSW
Pharmacists are likely aware that Wegovy® (semaglutide) is now available in Australia. The PDL Professional Officers have received several incident reports involving patients being supplied
The Wrong Patient incident type is a subset of dispensing incidents that continue to be highly reported to PDL. This almost entirely preventable error occurs
As of 16 August, SafeScript has introduced updated features designed to enhance the user experience. The update that relates to pharmacists is the improved visibility
Pharmacies in NSW providing a UTI service must meet the requirements of the Authority. Under this authority, pharmacies are required to maintain an up-to-date UTI
The Pharmacy Board of Australia’s revised Guidelines on compounding of medicines, which will take effect from 1 October 2024, is a timely reminder of the
Information from the Pharmaceutical Services Unit (PSU) The PDL Professional Officers often receive enquiries relating to the validity of psychostimulant prescriptions written for NSW patients.
New opportunities and changes continue for Queensland pharmacists, and PDL would like to remind Qld-based members of these changes for the benefit of patients and
Understanding the click method PDL has become aware of a number of adverse events and health consequences from the popularised method of OZEMPIC® (semaglutide) administration
From 1 July 2024, pharmacists in Tasmania can offer resupply of the oral contraceptive pill (OCP) without a doctor’s prescription to individuals who meet specific
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.